The role of the immune system in regulating the microbiota

A diverse population of bacteria, archaea, and fungi, collectively known as the microbiota, abounds within the gastrointestinal tract of the mammalian host. This microbial population makes many important contributions to host physiology through inter-kingdom signalling and by providing nutrients that have both local and systemic effects. In a healthy state the overall host-microbial interaction is symbiotic; however, a growing number of diseases have been associated with a dysregulated microbiota. To avoid these consequences, the host exerts substantial effort to maintain proper regulation of the microbiota with respect to localization and composition. Although important to maintaining microbial balance, the host immune response can also be the cause of a disrupted microbiota, contributing to disease severity. Here, we discuss the role of the host in both maintaining and disrupting a balanced gastrointestinal microbiota.

[1]  R. Drongowski,et al.  Probiotics upregulate MUC-2 mucin gene expression in a Caco-2 cell-culture model , 2003 .

[2]  M. Weichenthal,et al.  Reduced Paneth Cell &agr;-Defensins and Antimicrobial Activity in Ileal Crohn's Disease , 2006 .

[3]  Willem M. de Vos,et al.  The Host Genotype Affects the Bacterial Community in the Human Gastrointestinal Tract , 2001 .

[4]  Susan D. Spencer,et al.  The Orphan Receptor CRF2-4 Is an Essential Subunit of the Interleukin 10 Receptor , 1998, The Journal of experimental medicine.

[5]  C. Manichanh,et al.  Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.

[6]  J. Jansson,et al.  Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease , 2009, PloS one.

[7]  R. Ley,et al.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes , 2008, Nature.

[8]  S. Fagarasan.  Intestinal IgA synthesis: a primitive form of adaptive immunity that regulates microbial communities in the gut. , 2006, Current topics in microbiology and immunology.

[9]  F. Powrie,et al.  Regulatory lymphocytes and intestinal inflammation. , 2009, Annual review of immunology.

[10]  J. Gordon,et al.  Genomic and Metabolic Studies of the Impact of Probiotics on a Model Gut Symbiont and Host , 2006, PLoS biology.

[11]  Janet K. Jansson,et al.  Twin studies reveal specific imbalances in the mucosa‐associated microbiota of patients with ileal Crohn's disease , 2009, Inflammatory bowel diseases.

[12]  E. Telemo,et al.  A Full Flora, but not Monocolonization by Escherichia coli or Lactobacilli, Supports Tolerogenic Processing of a Fed Antigen , 2005, Scandinavian journal of immunology.

[13]  P. Ogra,et al.  Mucosal immunity and viral infections , 2001, Annals of medicine.

[14]  M. Weichenthal,et al.  Reduced Paneth cell α-defensins in ileal Crohn's disease , 2005 .

[15]  S. Keilbaugh,et al.  Activation of RegIIIbeta/gamma and interferon gamma expression in the intestinal tract of SCID mice: an innate response to bacterial colonisation of the gut. , 2005, Gut.

[16]  M. Hollingsworth,et al.  Probiotics inhibit enteropathogenic E. coliadherence in vitro by inducing intestinal mucin gene expression. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[17]  I. Wilson,et al.  Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. , 2007, Journal of proteome research.

[18]  R. Lehrer,et al.  Bactericidal properties of murine intestinal phospholipase A2. , 1995, The Journal of clinical investigation.

[19]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.

[20]  B. Finlay,et al.  Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. , 2007, Cell host & microbe.

[21]  B. Finlay,et al.  Antibiotic-Induced Perturbations of the Intestinal Microbiota Alter Host Susceptibility to Enteric Infection , 2008, Infection and Immunity.

[22]  A. Murphy,et al.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. , 2008, Immunity.

[23]  M. Kagnoff,et al.  Cell Differentiation Is a Key Determinant of Cathelicidin LL-37/Human Cationic Antimicrobial Protein 18 Expression by Human Colon Epithelium , 2002, Infection and Immunity.

[24]  W. Walker,et al.  TLRs in the Gut I. The role of TLRs/Nods in intestinal development and homeostasis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[25]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[26]  M. Abreu,et al.  Role of Toll-like receptors in gastrointestinal malignancies , 2008, Oncogene.

[27]  P. Toivanen,et al.  Influence of Major Histocompatibility Complex on Bacterial Composition of Fecal Flora , 2001, Infection and Immunity.

[28]  A. Mahmood,et al.  Postnatal changes in biosynthesis of microvillus membrane glycans of rat small intestine: I. Evidence of a developmental shift from terminal sialylation to fucosylation. , 1984, Biochemical and biophysical research communications.

[29]  C. Holdsworth,et al.  Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. , 1992, Gut.

[30]  Patrick Serrant,et al.  Effect of Lactobacillus paracasei NCC2461 on antigen-specific T-cell mediated immune responses in aged mice. , 2008, Rejuvenation research.

[31]  D. Strachan,et al.  Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility , 2008, Nature Genetics.

[32]  F. Bäckhed,et al.  Host-Bacterial Mutualism in the Human Intestine , 2005, Science.

[33]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[34]  A. Macpherson,et al.  Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria , 2004, Science.

[35]  Les Dethlefsen,et al.  The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing , 2008, PLoS biology.

[36]  R. J. Hocking,et al.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.

[37]  L. Eckmann,et al.  Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface , 2008, Proceedings of the National Academy of Sciences.

[38]  Dereje D. Jima,et al.  Enhanced transcription of complement and coagulation genes in the absence of adaptive immunity. , 2009, Molecular immunology.

[39]  L. Holm,et al.  The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[40]  R. Reifen,et al.  Bacterial population and innate immunity-related genes in rat gastrointestinal tract are altered by vitamin A-deficient diet. , 2009, The Journal of nutritional biochemistry.

[41]  P. Brandtzaeg.  Induction of secretory immunity and memory at mucosal surfaces. , 2007, Vaccine.

[42]  Nigel J. Saunders,et al.  CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent Mechanisms , 2003, The Journal of experimental medicine.

[43]  N. Salzman,et al.  Enteric Salmonellosis Disrupts the Microbial Ecology of the Murine Gastrointestinal Tract , 2007, Infection and Immunity.

[44]  P. Godowski,et al.  Cutting Edge: Bacterial Flagellin Activates Basolaterally Expressed TLR5 to Induce Epithelial Proinflammatory Gene Expression1 , 2001, The Journal of Immunology.

[45]  M. Weichenthal,et al.  Reduced Paneth cell alpha-defensins in ileal Crohn's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  C. Winckler,et al.  Colonic fermentation as affected by antibiotics and acidic pH: Application of an in vitro model. , 2001, Zeitschrift fur Gastroenterologie.

[47]  R Balfour Sartor,et al.  Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. , 2008, Cell host & microbe.

[48]  J. Gordon,et al.  Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem. , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[49]  Haifeng Lu,et al.  Symbiotic gut microbes modulate human metabolic phenotypes , 2008, Proceedings of the National Academy of Sciences.

[50]  S. Mazmanian,et al.  An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System , 2005, Cell.

[51]  A. Servin,et al.  Escherichia coli strains colonising the gastrointestinal tract protect germfree mice againstSalmonella typhimuriuminfection , 2001, Gut.

[52]  Tomas Hrncir,et al.  Nod2 is required for the regulation of commensal microbiota in the intestine , 2009, Proceedings of the National Academy of Sciences.

[53]  Shadi Sepehri,et al.  High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease , 2006, Gut.

[54]  Mario Vaneechoutte,et al.  Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora , 2008, Inflammatory bowel diseases.

[55]  L. Hooper,et al.  Symbiotic Bacteria Direct Expression of an Intestinal Bactericidal Lectin , 2006, Science.

[56]  Adam Godzik,et al.  Shotgun metaproteomics of the human distal gut microbiota , 2008, The ISME Journal.

[57]  J. Fallon,et al.  Developmental regulation of cryptdin, a corticostatin/defensin precursor mRNA in mouse small intestinal crypt epithelium , 1989, The Journal of cell biology.

[58]  R. Knight,et al.  Evolution of Mammals and Their Gut Microbes , 2008, Science.

[59]  R. Ley,et al.  Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine , 2006, Cell.

[60]  G. Dougan,et al.  Salmonella enterica Serovar Typhimurium Exploits Inflammation to Compete with the Intestinal Microbiota , 2007, PLoS biology.

[61]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[62]  Christophe Caron,et al.  Towards the human intestinal microbiota phylogenetic core. , 2009, Environmental microbiology.

[63]  J. Hampe,et al.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease , 2004, Gut.

[64]  P. Valdez,et al.  Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis , 2007, Nature.

[65]  B. Kelsall,et al.  Innate and adaptive mechanisms to control of pathological intestinal inflammation , 2008 .

[66]  T. Ganz.  Antimicrobial polypeptides , 2004, Journal of leukocyte biology.

[67]  L. Hooper,et al.  Reciprocal Interactions between Commensal Bacteria and γδ Intraepithelial Lymphocytes during Mucosal Injury1 , 2009, The Journal of Immunology.

[68]  J. Jansson,et al.  Long-term ecological impacts of antibiotic administration on the human intestinal microbiota , 2013, The ISME Journal.

[69]  A. Gurney,et al.  Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17* , 2003, The Journal of Biological Chemistry.

[70]  P. Sansonetti.  Host–bacteria homeostasis in the healthy and inflamed gut , 2008, Current opinion in gastroenterology.

[71]  Harry J. Flint,et al.  Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. , 2009, FEMS microbiology letters.

[72]  A. Imaoka,et al.  Segmented Filamentous Bacteria Are Indigenous Intestinal Bacteria That Activate Intraepithelial Lymphocytes and Induce MHC Class II Molecules and Fucosyl Asialo GM1 Glycolipids on the Small Intestinal Epithelial Cells in the Ex‐Germ‐Free Mouse , 1995, Microbiology and immunology.

[73]  S. Akira,et al.  Deletion of TLR5 results in spontaneous colitis in mice. , 2007, The Journal of clinical investigation.

[74]  R. Zinkernagel,et al.  Mechanisms of Neonatal Mucosal Antibody Protection1 , 2006, The Journal of Immunology.

[75]  A. Mokrowiecka,et al.  Clinical utility of serological markers in inflammatory bowel disease. , 2009, Hepato-gastroenterology.

[76]  K. Takeda,et al.  Regulatory mechanisms of immune responses to intestinal bacteria , 2009, Mucosal Immunology.

[77]  Bernard Henrissat,et al.  Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla , 2009, Proceedings of the National Academy of Sciences.

[78]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[79]  Elaine Holmes,et al.  Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes , 2008, Molecular systems biology.

[80]  M. Hollingsworth,et al.  Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro , 2003, Gut.

[81]  G. Tannock.  The search for disease-associated compositional shifts in bowel bacterial communities of humans. , 2008, Trends in microbiology.

[82]  A. Imaoka,et al.  Differential Roles of Segmented Filamentous Bacteria and Clostridia in Development of the Intestinal Immune System , 1999, Infection and Immunity.

[83]  R. Xavier,et al.  IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. , 2008, The Journal of clinical investigation.

[84]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[85]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[86]  I. Fuss.  Is the Th1/Th2 paradigm of immune regulation applicable to IBD? , 2008, Inflammatory bowel diseases.

[87]  D. Teitelbaum,et al.  Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model , 2002, Pediatric Surgery International.

[88]  G. Weinstock,et al.  Enteric defensins are essential regulators of intestinal microbial ecology , 2009, Nature Immunology.

[89]  James M. Wilson,et al.  Cathelicidins - a family of multifunctional antimicrobial peptides , 2003, Cellular and Molecular Life Sciences CMLS.

[90]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[91]  G. Rechkemmer,et al.  Clinical Evidence for Immunomodulatory Effects of Probiotic Bacteria , 2009, Journal of pediatric gastroenterology and nutrition.

[92]  V. Kuchroo,et al.  Th17 cells: effector T cells with inflammatory properties. , 2007, Seminars in immunology.

[93]  R. Medzhitov,et al.  Regulation of Spontaneous Intestinal Tumorigenesis Through the Adaptor Protein MyD88 , 2007, Science.

[94]  C. Hoyen.  Factors Influencing the Composition of the Intestinal Microbiota in Early Infancy , 2007 .

[95]  G. Hecht,et al.  Innate mechanisms of epithelial host defense: spotlight on intestine. , 1999, American journal of physiology. Cell physiology.

[96]  J. Cebra,et al.  Influences of microbiota on intestinal immune system development. , 1999, The American journal of clinical nutrition.

[97]  H. Lochs,et al.  Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel Disease , 2005, Journal of Clinical Microbiology.

[98]  Ronald P. DeMatteo,et al.  Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits , 2008, Nature.

[99]  F. Shanahan,et al.  The normal intestinal microbiota , 2007, Current opinion in infectious diseases.

[100]  J. Gordon,et al.  IgA response to symbiotic bacteria as a mediator of gut homeostasis. , 2007, Cell host & microbe.

[101]  Keiichiro Suzuki,et al.  Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[102]  Judy H Cho,et al.  Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[103]  Jeffrey I. Gordon,et al.  Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[104]  Lena Holm,et al.  The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria , 2010, Gut microbes.

[105]  L. Hooper,et al.  Bacterial contributions to mammalian gut development. , 2004, Trends in microbiology.

[106]  W. R. Wikoff,et al.  Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites , 2009, Proceedings of the National Academy of Sciences.

[107]  M. Selsted,et al.  Mammalian defensins in the antimicrobial immune response , 2005, Nature Immunology.

[108]  R. Zinkernagel,et al.  A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. , 2000, Science.

[109]  A. Darzi,et al.  The gut microbiota as a target for improved surgical outcome and improved patient care. , 2009, Current pharmaceutical design.

[110]  F. Shanahan,et al.  Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease , 2006, Journal of Clinical Microbiology.

[111]  Jeffrey I. Gordon,et al.  Reciprocal Gut Microbiota Transplants from Zebrafish and Mice to Germ-free Recipients Reveal Host Habitat Selection , 2006, Cell.

[112]  M. Hornef,et al.  Secreted enteric antimicrobial activity localises to the mucus surface layer , 2008, Gut.

[113]  J. Hugot,et al.  Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn’s disease colon , 2003, Gut.

[114]  J. Mestecky,et al.  Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces , 2009, Immunology Letters.

[115]  Philippe Marteau,et al.  Specificities of the fecal microbiota in inflammatory bowel disease , 2006, Inflammatory bowel diseases.

[116]  I. Adlerberth.  Factors influencing the establishment of the intestinal microbiota in infancy. , 2008, Nestle Nutrition workshop series. Paediatric programme.

[117]  T Midtvedt,et al.  A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[118]  K. Papadakis,et al.  Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease. , 2007, Clinical immunology.

[119]  J. Jansson,et al.  Molecular analysis of the gut microbiota of identical twins with Crohn's disease , 2008, The ISME Journal.

[120]  B. Finlay,et al.  Chronic enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis. , 2008, Gastroenterology.

[121]  M. Hornef,et al.  Increased diversity of intestinal antimicrobial peptides by covalent dimer formation , 2004, Nature Immunology.

[122]  M. Abreu,et al.  TLR Signaling in the Gut in Health and Disease1 , 2005, The Journal of Immunology.

[123]  G. Wu,et al.  How to evaluate a gastric submucosal tumour in a patient with haematemesis? , 2005, Gut.

[124]  J. Gordon,et al.  Commensal Host-Bacterial Relationships in the Gut , 2001, Science.

[125]  Keiichiro Suzuki,et al.  Critical Roles of Activation-Induced Cytidine Deaminase in the Homeostasis of Gut Flora , 2002, Science.

[126]  Manfred Dietel,et al.  Mucosal flora in inflammatory bowel disease. , 2002, Gastroenterology.

[127]  C. Biron,et al.  NK cells and NKT cells in innate defense against viral infections. , 2001, Current opinion in immunology.

[128]  J. Browning,et al.  Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states. , 1993, Journal of lipid mediators.

[129]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[130]  Thomas F. Tedder,et al.  Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism , 2009, Science.